Cyclic Peptide [R4W4] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas
Tuberculosis (TB) is currently one of the leading causes of global mortality. Medical non-compliance due to the length of the treatment and antibiotic side effects has led to the emergence of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis (M. tb) that are difficult to treat. A curre...
Main Authors: | Joshua Hernandez, David Ashley, Ruoqiong Cao, Rachel Abrahem, Timothy Nguyen, Kimberly To, Aram Yegiazaryan, Ajayi Akinwale David, Rakesh Kumar Tiwari, Vishwanath Venketaraman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01677/full |
Similar Items
-
Antimycobacterial Effects of Everolimus in a Human Granuloma Model
by: David Ashley, et al.
Published: (2020-06-01) -
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
by: Kimberly To, et al.
Published: (2020-08-01) -
Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
by: Rachel Abrahem, et al.
Published: (2019-09-01) -
The Role of Dendritic Cells in TB and HIV Infection
by: Rachel Abrahem, et al.
Published: (2020-08-01) -
Recent Advances in Mycobacterial Research
by: Vishwanath Venketaraman
Published: (2020-08-01)